When most people think of melanoma, they think of skin cancer. If left untreated, melanoma can spread throughout the body.
Melanoma News
Immune markers in blood could predict toxicity and treatment response to immunotherapy in melanoma
New research identifies blood-based B cell and antibody signatures that could guide safer treatment for patients receiving immunotherapy.
Study Shows that Existing Drug Class May Help Patients with Skin Cancer that Resists Standard Treatments
ncreased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new study shows.
EGFR Inhibitors Could Be Effective Treatment for NF1 Melanoma Subtype
A team of researchers at NYU Langone Health and the Perlmutter Cancer Center has identified a potential therapeutic strategy for melanoma patients whose tumors harbor mutations in the neurofibromin 1 (NF1) gene and who do not respond to current immunotherapy treatments.